Bioequivalence study of Prontogest 100 mg/2 mL solution for intramuscular injection versus reference progesterone injection, USP 500 mg/10 mL under fasting conditions: a randomized, open-label, two-sequence, four-period, fully replicated crossover study in healthy postmenopausal women